Does RISANKIZUMAB-RZAA Cause Tuberculosis? 199 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 199 reports of Tuberculosis have been filed in association with RISANKIZUMAB-RZAA. This represents 0.3% of all adverse event reports for RISANKIZUMAB-RZAA.
199
Reports of Tuberculosis with RISANKIZUMAB-RZAA
0.3%
of all RISANKIZUMAB-RZAA reports
0
Deaths
12
Hospitalizations
How Dangerous Is Tuberculosis From RISANKIZUMAB-RZAA?
Of the 199 reports, 12 (6.0%) required hospitalization, and 1 (0.5%) were considered life-threatening.
Is Tuberculosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 199 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Tuberculosis?
INFLIXIMAB (1,247)
ADALIMUMAB (1,047)
METHOTREXATE (817)
ETANERCEPT (632)
GOLIMUMAB (413)
CERTOLIZUMAB PEGOL (399)
SECUKINUMAB (396)
TOFACITINIB (301)
PREDNISONE (283)
ISONIAZID (261)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Tuberculosis Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA